Your browser doesn't support javascript.
loading
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study.
Magnolo, Nina; Kingo, Külli; Laquer, Vivian; Browning, John; Reich, Adam; Szepietowski, Jacek C; Keefe, Deborah; Papanastasiou, Philemon; Bao, Weibin; Forrer, Pascal; Patekar, Manmath.
Afiliação
  • Magnolo N; University Hospital Münster, Münster, Germany. Nina.Magnolo@ukmuenster.de.
  • Kingo K; Tartu University Hospital and University of Tartu, Tartu, Estonia.
  • Laquer V; First OC Dermatology, Fountain Valley, CA, USA.
  • Browning J; University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Reich A; Department of Dermatology, Institute of Medical Science, Medical College of Rzeszów University, Rzeszów, Poland.
  • Szepietowski JC; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Keefe D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Papanastasiou P; Novartis Pharma AG, Basel, Switzerland.
  • Bao W; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Forrer P; Novartis Pharma AG, Basel, Switzerland.
  • Patekar M; Novartis Pharma AG, Basel, Switzerland.
Paediatr Drugs ; 24(4): 377-387, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35698000
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article